OP
ADMA icon

ORG Partners’s ADMA Biologics ADMA Stock Holding History

ORG Partners’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$912 Hold
50
– – ﹤0.01% 1551
2025
Q3 		$733 Sell
50
-25
-33% -$429 ﹤0.01% 1428
2025
Q2 		$1.34K Buy
75
+25
+50% +$510 ﹤0.01% 1294
2025
Q1 		$971 Buy
+50
New +$865 ﹤0.01% 1179

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

ORG Partners's ADMA Position: Q4 2025 in Review

ORG Partners held its ADMA Biologics (ADMA) position steady in Q4 2025 at 50 shares worth $912. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

ORG Partners first reported a position in ADMA in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.34K in Q2 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q4 2025.

  • ORG Partners held 50 shares of ADMA Biologics worth $912 as of Q4 2025.
  • ORG Partners left its ADMA Biologics share count unchanged in Q4 2025.
  • ADMA Biologics made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1551 holding.
  • ORG Partners first reported a position in ADMA Biologics in Q1 2025 and has held it in 4 quarters since.
  • ORG Partners's ADMA Biologics position peaked at $1.34K in Q2 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.